awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38915115-2F28ABC8-7AF2-4F7D-BC1D-8CDC2C46828B
Q38915115-2F28ABC8-7AF2-4F7D-BC1D-8CDC2C46828B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38915115-2F28ABC8-7AF2-4F7D-BC1D-8CDC2C46828B
Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism.
P2860
Q38915115-2F28ABC8-7AF2-4F7D-BC1D-8CDC2C46828B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38915115-2F28ABC8-7AF2-4F7D-BC1D-8CDC2C46828B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f60875dff70dc80d8bfb6bbb9a8cac2baea5703f
P2860
Combined anticancer effects of sphingosine kinase inhibitors and sorafenib.